BREAKING
Home » Archive by Category "Drugs and antibiotics"

Inhaled antibody therapy to protect against new COVID variants

By

By NewsDesk  @bactiman63 Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, announced...

Marburg Virus Disease

New drug target for Ebola, Marburg viruses

By

Ebola and Marburg are among the most deadly viruses, with mortality rates from these infections ranging from 25% to 90%. While no drugs currently are available on the market to prevent infection from these...

Ivermectin: South Africa officials say routine use for either the prevention or treatment of COVID-19 is not justified

By

By News Desk  @bactiman63 The Ministerial Advisory Committee (MAC) on COVID-19 in South Africa released a memo recently concerning the use of ivermectin for the prevention or treatment of COVID-19. The...

HIV drug, Cabenuva, approved by FDA; 1st injectable regimen

By

The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1)...

CBD can kill gonorrhea bacteria: University of Queensland study

By

Synthetic cannabidiol, better known as CBD, has been shown for the first time to kill the bacteria responsible for gonorrhea, meningitis and legionnaires disease. The research collaboration between The...

NIH changes on use of ivermectin for treatment of COVID-19

By

By News Desk  @bactiman63 In August 2020, the National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel firmly said of the use of ivermectin: The COVID-19 Treatment Guidelines Panel recommends...

FDA approves Ebanga for the treatment of Ebola

By

By News Desk  @bactiman63 Biotechnology company, Ridgeback Biotherapeutics, announced recently that the U.S. Food and Drug Administration (FDA) approved EbangaTM for the treatment of Ebola. Ebanga...

Vir Biotechnology & Gilead Announce Phase 2 Clinical Trial Collab for Functional Cure of Hepatitis B Virus

By

Gilead Sciences, Inc. and Vir Biotechnology, Inc. announced this week that the companies have entered into a clinical collaboration to evaluate novel therapeutic combination strategies aimed at developing...

Australia: GSK, MMV filing for Kozenis (tafenoquine) in pediatric populations accepted

By

GSK and Medicines for Malaria Venture (MMV) announced today that the Australian Therapeutic Goods Administration (TGA) accepted the submission of a Category 1 application to extend the indication of single-dose...

Eliminate sleeping sickness before 2030: Sanofi supports WHO in commitment

By

Sanofi has signed on December 10th a renewed partnership agreement with the World Health Organization (WHO), consolidating a 20-year collaboration to fight some of the most Neglected Tropical Diseases...